Skip to main content
. 2017 Feb 6;7:42016. doi: 10.1038/srep42016

Figure 6. CAPE-treated cells showed remarkable decrease in nuclear mortalin.

Figure 6

CAPE-treated MDA-MB 231 cells showed downregulation of mortalin and calreticulin. Dose response analyses showed stronger effect on mortalin than calreticulin (A). Co-immunostaining of mortain and nuclear protein hnRNP-K showed reduction in mortalin and its remarkable clearance from the nucleus (B) IMARIS images of control and CAPE-treated cells showing reduction in nuclear mortalin, shown by white arrows (D).